Description
Everolimus, known as Afinitor, is a versatile treatment option used for various medical conditions. It’s employed for advanced renal cell carcinoma (RCC) after other treatments have proven ineffective. Additionally, it tackles advanced breast cancer and certain types of pancreatic, stomach, intestinal, or lung cancers that can’t be surgically treated. For those with tuberous sclerosis complex (TSC), it addresses kidney tumors and subependymal giant cell astrocytoma (SEGA) brain tumors in both adults and children over one year of age. Everolimus, whether as Afinitor or Afinitor Disperz, acts as a kinase inhibitor, thwarting cancer cell growth and restricting blood supply to these cells. In the form of Zortress, it assists in preventing transplant rejection after kidney transplants by moderating immune system activity.